COVID-19 infection in 50 patients receiving lithium

Janusz Rybakowski

doi:10.33450/fpn.2021.06.002

eISSN: 2449-9315
ISSN: 1234-8279

Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii

Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury

Panel Redakcyjny

Zgłaszanie i recenzowanie prac online

Wyszukiwanie

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Bez opłat za publikację

Otwarty dostęp

2/2021
vol. 37

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

Artykuł oryginalny

Występowanie zakażenia COVID-19 u 50 pacjentów otrzymujących lit

Janusz Rybakowski

¹

Poznan University of Medical Sciences, Department of Adult Psychiatry

Farmakoterapia w Psychiatrii i Neurologii 2021, 37 (2), 113–121

DOI: https://doi.org/10.33450/fpn.2021.06.002

Data publikacji online: 2021/12/07

Plik artykułu:

- 01R_IPiN_FARM_2021-2D.pdf [0.14 MB]

Pobierz cytowanie

Metryki PlumX:

1. Amsterdam JD, García-España F, Rybakowski J. Rates of flulike infection in patients with affective illness. J Affect Disord 1998; 47: 177-182.

2. Dotson S, Hartvigsen N, Wesner T, Carbary TJ, Fricchione G, Freudenreich O. Clozapine toxicity in the setting of COVID-19. Psychosomatics. 2020; 61: 577-578.

3. Gattner K, Rybakowski J. A severe course of the COVID-19 in a patient receiving prophylactically lithium. Pharmacother Psychiatry Neurol 2020; 36: 143-148.

4. Lieb J. Remission of recurrent herpes infection during therapy with lithium. N Eng J Med 1979; 301: 942.

5. Llesuy JR, Sidelnik SA. Death from COVID-19 in a patient receiving clozapine: Factors involved and prevention strategies to consider. Prim Care Companion CNS Disord. 2020; 22: 20l02699.

6. Murru A, Manchia M, Hajek T, Nielsen RE, Rybakowski JK, Sani G et al. Lithium’s antiviral effects: a potential drug for COVID-19 disease? Int J Bipolar Disord. 2020; 8: 21.

7. Nowak JK, Walkowiak J. Lithium and coronavirus infections. A scoping review. F1000Research 2020; 9: 93.

8. Qaswal AB, Guzu H, Suleiman A, Atiyat B. The potential role of lithium as an antiviral agent against SARS-CoV-2 via membrane depolarization: review and hypothesis. Sci Pharm 2021; 89; 11.

9. Rajkumar RP. Lithium as a candidate treatment for COVID-19: Promises and pitfalls. Drug Dev Res. 2020; 81: 782-785.

10. Rudd CE. Commentary: Does lithium deserve a place in the treatment against COVID-19? A preliminary observational study in six patients, case report. Front Pharmacol. 2020a; 11: 613734.

11. Rudd CE. GSK-3 inhibition as a therapeutic approach against SARs CoV2: Dual benefit of inhibiting viral replication while potentiating the immune response. Front Immunol 2020b; 11: 1638.

12. Rybakowski J. Informacja dotycząca stosowania litu w okresie pandemii COVID-19. Psychiatra 2020; 28: 48-49.

13. Rybakowski JK, Amsterdam JD. Lithium prophylaxis and recurrent labial herpes infections. Lithium 1991; 2: 43-47.

14. Rybakowski JK, Suwalska A, Hajek T. Clinical perspectives of lithium’s neuroprotective effect. Pharmacopsychiatry 2018; 51: 194-199.

15. Rybakowski JK. Antiviral and immunomodulatory effect of lithium. Pharmacopsychiatry 2000; 33: 159-164. 16. Severus E, Taylor MJ, Sauer C, Pfennig A, Ritter P, Bauer M et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord 2014; 2: 15.

16. Skinner GRB, Hartley C, Buchan A, Harper L, Gallimore P. The effect of lithium chloride on the replication of herpes simplex virus. Med Microbiol Immunol 1980; 168: 258-265.

17. Smith KA, Cipriani A. Lithium and suicide in mood disorders: Updated meta-review of the scientific literature. Bipolar Disorders 2017; 19: 575-586.

18. Spuch C, López-García M, Rivera-Baltanás T, Rodrígues- Amorím D, Olivares JM. Does lithium deserve a place in the treatment against COVID-19? A preliminary observational study in six patients, case report. Front Pharmacol. 2020; 11: 557629.

19. Suwanwongse K, Shabarek N. Lithium toxicity in two coronavirus disease 2019 (COVID-19) patients. Cureus. 2020; 12: e8384

Występowanie zakażenia COVID-19 u 50 pacjentów otrzymujących lit

Janusz Rybakowski 1

Janusz Rybakowski

¹